Showing results (321-330 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|May 16, 2024
Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung CancerJeanna Wallenta Law, Bela Bapat, Connor Sweetnam, et al.
JCO Precision Oncology|December 18, 2025
Multicancer Early Detection Blood Test Performance in Cancer Survivors From the PATHFINDER StudyCatherine R Marinac, Elizabeth K O'Donnell, Christina A Clarke, et al.
JCO Precision Oncology|November 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo ClinicOudai Sahwan, Fares Jamal, Rish Pai, et al.
JCO Precision Oncology|May 1, 2024
Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS MetastasesKathryn R Tringale, Anna Skakodub, Jacklynn Egger, et al.
JCO Precision Oncology|April 25, 2024
Characterization of BRAFThr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic ProfilingHirofumi Watanabe, Yusuke Inoue, Masato Karayama, et al.
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
JCO Precision Oncology|May 1, 2024
Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral NeuropathyNicole Yeung, Tiffany Li, Hui-Ming Lin, et al.
JCO Precision Oncology|May 6, 2024
Are FGFR Fusions and Mutations the Next Tumor-Agnostic Targets in Oncology?Haley Ellis, Lipika Goyal
JCO Precision Oncology|April 18, 2024
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening ProjectMasaya Hattori, Victoria Serelli-Lee, Yoichi Naito, et al.
JCO Precision Oncology|December 14, 2023
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry StudyFunda Meric-Bernstam, Michael Rothe, Pam K Mangat, et al.
Pageof 140